Bifidobacterium adolescentis – BA02 (DSM 18351, formerly ALB 1)

    Gastroenterology strain | Constipation – Intestinal transit

    Characteristics

    DAILY DOSAGE IN CLINICAL STUDY
    10 billion CFU

    FUNCTIONALITY
    Constipation • Intestinal transit

    Scientific support

    Human clinical trial
    Del Piano M. et al. The use of probiotics in the treatment of constipation in the elderly (BL03, LP01, BS01, LR05, BA02 and BR03 seperately). CIBUS, 2005; 1(1):23-30.

    In vitro studies
    a) Del Piano M. et al. In Vitro Sensitivity of Probiotics to Human Pancreatic Juice (LA02, LPC00, LP01, LR04, BR03, BL03 and BA02). J Clin Gastroenterol. Vol 42, Suppl. 3, Part 2, Sept. 2008.
    b) Rossi M. et al. fermentation of fructooligosaccharides and inulin by Bifidobacteria: a comparative study of pure and fecal cultures (BA02). Applied and Environmental Microbiology, 2005;71(10):6150-6158.